Correlation Between Artha Optimum and Novo Nordisk

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Artha Optimum and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artha Optimum and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artha Optimum AS and Novo Nordisk AS, you can compare the effects of market volatilities on Artha Optimum and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artha Optimum with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artha Optimum and Novo Nordisk.

Diversification Opportunities for Artha Optimum and Novo Nordisk

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Artha and Novo is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Artha Optimum AS and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Artha Optimum is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artha Optimum AS are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Artha Optimum i.e., Artha Optimum and Novo Nordisk go up and down completely randomly.

Pair Corralation between Artha Optimum and Novo Nordisk

Assuming the 90 days trading horizon Artha Optimum AS is expected to generate 0.12 times more return on investment than Novo Nordisk. However, Artha Optimum AS is 8.28 times less risky than Novo Nordisk. It trades about -0.04 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.02 per unit of risk. If you would invest  604,650  in Artha Optimum AS on August 29, 2024 and sell it today you would lose (1,200) from holding Artha Optimum AS or give up 0.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy86.36%
ValuesDaily Returns

Artha Optimum AS  vs.  Novo Nordisk AS

 Performance 
       Timeline  
Artha Optimum AS 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Artha Optimum AS are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Artha Optimum is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Artha Optimum and Novo Nordisk Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Artha Optimum and Novo Nordisk

The main advantage of trading using opposite Artha Optimum and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artha Optimum position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.
The idea behind Artha Optimum AS and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope